Ginsenoside Re: Pharmacological Effects on Cardiovascular System

Cardiovascular Therapeutics

Volumn 30, Issue 4, 2012, Pages

  Peng, Lu ^a,b   Sun, Shi ^c   Xie, Lai Hua ^d   Wicks, Sheila M ^e   Xie, Jing Tian ^b,f  

^a Beijing Jishuitan Hospital   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c INSTITUTE OF BOTANY   (China)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e One of the City Colleges of Chicago   (United States)

^f Medical College of Shangqiu   (China)

Author keywords

Cardiovascular system; Chemistry; Electrophysiology; Ginseng; Ginsenoside Re; Pharmacological effect

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; GINSENG EXTRACT; GINSENOSIDE RB 1; GINSENOSIDE RC; GINSENOSIDE RE; GINSENOSIDE RF; GINSENOSIDE RG 1; PROTEIN BAX; PROTEIN BCL 2; VERAPAMIL;

ANGIOGENESIS; ANTIARRHYTHMIC ACTIVITY; CARDIOVASCULAR SYSTEM; DRUG EFFECT; HEART CONTRACTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; NEUROPROTECTION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

ACTION POTENTIALS; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOTONIC AGENTS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; GINSENOSIDES; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MYOCARDIAL CONTRACTION; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84863434733     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2011.00271.x     Document Type: Review

References (58)

1. Lu JM, Yao Q, Chen C. Ginseng compounds: An update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009;7:293-302.
2. Peng DC, Chen WP, Xie JT. Antihyperglycemic effects of ginseng and possible mechanisms. Drugs Future 2008;33:507-514.
3. Cho WC. Ginseng, Panax ginseng CA Meyer. In: Awaad AS, Singh VK, Govil JN, editors. Recent Progress in Medicinal Plants, Volume 28, Drug Plants II. Houston, USA: Studium Press LLC, 2010;19-30.
4. Chevallier A. Encyclopedia of herbal medicine. New York : DK Publishing Inc., 2000.
5. Hu SY. A contribution to our knowledge of ginseng. Am J Chin Med 1977;5:1-23.
6. Attele AS, Wu JA, Yuan CS. Multiple pharmacological effects of ginseng. Biochem Pharmacol 1999;58:1685-1693.
7. Attele AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002;51:1851-1858.
8. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9:259-274.
9. Lee TK, Johnke RM, Allison RR, O'Brien KF, Dobbs LJ, Jr. Radioprotective potential of ginseng. Mutagenesis 2005;20:237-243.
10. Xie JT, Mehendale SR, Li X, et al. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 2005;1740:319-325.
11. Cho WC, Yip TT, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS. J Ethnopharmacol 2006;108:272-279.
12. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 2006;550:173-179.
13. Xie JT, Shao ZH, Vanden Hoek TL, et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006;532:201-207.
14. Gillis CN. Panax ginseng pharmacology: A nitric oxide link?Biochem Pharmacol 1997;54:1-8.
15. Tachikawa E, Kudo K. Proof of the mysterious efficacy of ginseng: basic and clinical trials: Suppression of adrenal medullary function in vitro by ginseng. J Pharmacol Sci 2004;95:140-144.
16. Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005;26:143-149.
17. Christensen LP. Chapter 1 Ginsenosides: Chemistry, Biosynthesis, Analysis, and Potential Health Effects. Adv Food Nutr Res 2008;55:1-99.
18. Xie JT, Wang CZ, Wang AB, Wu JA, Basila D, Yuan CS. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng. Acta Pharmacol Sin 2005;26:1104-1110.
19. Joo KM, Lee JH, Jeon HY, et al. Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method. J Pharm Biomed Anal 2010;51:278-283.
20. Bai CX, Sunami A, Namiki T, Sawanobori T, Furukawa T. Electrophysiological effects of ginseng and ginsenoside Re in guinea pig ventricular myocytes. Eur J Pharmacol 2003;476:35-44.
21. 2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br J Pharmacol 2004;142:567-575.
22. 2+ channels and membrane capacitance in rat adrenal chromaffin cells. Brain Res Bull 1998;46:245-251.
23. Jin ZQ, Liu CM. Effect of ginsenoside Re on the electrophysiological activity of the heart. Planta Med 1994;60:192-193.
24. Jin ZQ. The action of ginsenoside Re on inotropy and chronotropy of isolated atria prepared from guinea pigs. Planta Med 1996;62:314-316.
25. Kim DH, Moon YS, Jung JS, Min SK, Son BK, Suh HW, Song DK. Effects of ginseng saponin administered intraperitoneally on the hypothalamo-pituitary-adrenal axis in mice. Neurosci Lett 2003;343(Suppl):62-66.
26. Wang Y, Yuan CS, Lipsius S. Ginsenoside Re experts anti-arrhythmic effects in cat ventricle myocytes. Exp Biol Abstr A277.
27. Mehendale S, Aung H, Wang A, Yin JJ, Wang CZ, Xie JT, Yuan CS. American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats. Cancer Chemother Pharmacol 2005;56:63-69.
28. 2. Int J Biochem Cell Biol 1998;30:327-338.
29. Bae EA, Shin JE, Kim DH. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol Pharm Bull 2005;28:1903-1908.
30. Xie JT, Attele AS, Yuan C-S. Ginseng: beneficial and potential adverse effects. In: Yuan C-S, Beiber E, Bauer BA, editors. A textbook of complementary and alternative therapies. Boca Raton, London, New York, Washington, D.C .: CRC Press Company, 2006;71-89.
31. Ourisson G, Crabbe P, Rodic OR. Tetracyclic triterpenes. San Francisco : Holden-Day Publisher, 1964.
32. Boar RB. Terpenoids and steroids. Dorking, UK : Bartholomew Press, 1983.
33. Shibata S, Tanaka O, Shoji J, Saito H. Chemistry and pharmacology of Panax. Econ Med Plant Res 1985;1:217-283.
34. Heftmann E, Mosetting E. Biochemistry of steroids. London : Reinhold Publishing Corporation, 1960.
35. Banthorpe DV. Natural products. Essex : Longman Scientific and Technical, 1994.
36. Leung KW, Wong AS. Pharmacology of ginsenosides: A literature review. Chin Med 2010; doi:.
37. Cheng D, Fu R, Dou D, Kang T. Study on the hemolytic and anti-hemolytic actions of individual ginsenosides. Zhongguo Xiandai Zhongyao 2007;94:19-23, 26.
38. Kang SY, Schini-Kerth VB, Kim ND. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sci 1995;56:1577-1586.
39. Ota T, Fujikawa-Yamamoto K, Zong ZP, et al. Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res 1987;47:3863-3867.
40. Xie JT, Aung HH, Wu JA, Attele AS, Yuan CS. Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am J Chin Med 2002;30:187-194.
41. Xie JT, Mehendale SR, Wang A, Aung HH, Wu JA, Osinski J, Yuan CS. American ginseng leaf: Ginsenoside analysis and hypoglycemic activity. Pharmacol Res 2004;49:113-117.
42. Wang H, Peng D, Xie JT. Ginseng leaf-stem: Bioactive constituents and pharmacological functions. Chin Med 2009;4:20-27.
43. Li TSC, Mazza G, Cottrell AC, Gao L. Ginsenosides in roots and leaves of American ginseng. J Agric Food Chem 1996;44:717-720.
44. Mizuno M, Yamada J, Terai H, Kozukue N, Lee YS, Tsuchida H. Differences in immunomodulating effects between wild and cultured Panax ginseng. Biochem Biophys Res Commun 1994;200:1672-1678.
45. Lim W, Mudge KW, Vermeylen F. Effects of population, age, and cultivation methods on ginsenoside content of wild American ginseng (Panax quinquefolium). J Agric Food Chem 2005;53:8498-8505.
46. Sritularak B, Morinaga O, Yuan CS, Shoyama Y, Tanaka H. Quantitative analysis of ginsenosides Rb1, Rg1, and Re in American ginseng berry and flower samples by ELISA using monoclonal antibodies. J Nat Med (Tokyo) 2009;63:360-363.
47. Morinaga O, Uto T, Yuan CS, Tanaka H, Shoyama Y. Evaluation of a new eastern blotting technique for the analysis of ginsenoside Re in American ginseng berry pulp extracts. Fitoterapia 2010;81:284-288.
48. Wang YG, Zima AV, Ji X, Pabbidi R, Blatter LA, Lipsius SL. Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes. Am J Physiol Heart Circ Physiol 2008;295:H851-H859.
49. Chen CX, Zhang HY. Protective effect of ginsenoside Re on isoproterenol-induced triggered ventricular arrhythmia in rabbits. Zhongguo Dang Dai Er Ke Za Zhi 2009;11:384-388.
50. Liu Z, Li Z, Liu X. Effect of ginsenoside Re on cardiomyocyte apoptosis and expression of Bcl-2/Bax gene after ischemia and reperfusion in rats. J Huazhong Univ Sci Technolog Med Sci 2002;22:305-309.
51. Chen LM, Zhou XM, Cao YL, Hu WX. Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats. J Asian Nat Prod Res 2008;10:439-445.
52. Scott GI, Colligan PB, Ren BH, Ren J. Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. Br J Pharmacol 2001;134:1159-1165.
53. Huang YC, Chen CT, Chen SC, et al. A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. Pharm Res 2005;22:636-646.
54. Yu LC, Chen SC, Chang WC, Huang YC, Lin KM, Lai PH, Sung HW. Stability of angiogenic agents, ginsenoside Rg1 and Re, isolated from Panax ginseng: in vitro and in vivo studies. Int J Pharm 2007;328:168-176.
55. Hayashi H, Shiferaw Y, Sato D, et al. Dynamic origin of spatially discordant alternans in cardiac tissue. Biophys J 2007;92:448-460.
56. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999;99:1385-1394.
57. Xie LH, Sato D, Garfinkel A, Qu Z, Weiss JN. Intracellular Ca alternans: Coordinated regulation by sarcoplasmic reticulum release, uptake, and leak. Biophys J 2008;95:3100-3110.
58. Furukawa T, Bai CX, Kaihara A, et al. Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sex hormones. Mol Pharmacol 2006;70:1916-192.